Cytochrome P4502C9 activity in end-stage renal disease [2]

Albert W. Dreisbach, Shanker Japa, Aster B. Gebrekal, Sarah E. Mowry, Juan J.L. Lertora, Burde L. Kamath, Allan E. Rettie

Research output: Contribution to journalLetter

73 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)475-477
Number of pages3
JournalClinical Pharmacology and Therapeutics
Volume73
Issue number5
DOIs
StatePublished - May 1 2003

Fingerprint

Aryl Hydrocarbon Hydroxylases
Warfarin
Cytochromes
Anticoagulants
Chronic Kidney Failure
Down-Regulation
Alleles
Genotype

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Dreisbach, A. W., Japa, S., Gebrekal, A. B., Mowry, S. E., Lertora, J. J. L., Kamath, B. L., & Rettie, A. E. (2003). Cytochrome P4502C9 activity in end-stage renal disease [2]. Clinical Pharmacology and Therapeutics, 73(5), 475-477. https://doi.org/10.1016/S0009-9236(03)00015-8

Cytochrome P4502C9 activity in end-stage renal disease [2]. / Dreisbach, Albert W.; Japa, Shanker; Gebrekal, Aster B.; Mowry, Sarah E.; Lertora, Juan J.L.; Kamath, Burde L.; Rettie, Allan E.

In: Clinical Pharmacology and Therapeutics, Vol. 73, No. 5, 01.05.2003, p. 475-477.

Research output: Contribution to journalLetter

Dreisbach, AW, Japa, S, Gebrekal, AB, Mowry, SE, Lertora, JJL, Kamath, BL & Rettie, AE 2003, 'Cytochrome P4502C9 activity in end-stage renal disease [2]', Clinical Pharmacology and Therapeutics, vol. 73, no. 5, pp. 475-477. https://doi.org/10.1016/S0009-9236(03)00015-8
Dreisbach AW, Japa S, Gebrekal AB, Mowry SE, Lertora JJL, Kamath BL et al. Cytochrome P4502C9 activity in end-stage renal disease [2]. Clinical Pharmacology and Therapeutics. 2003 May 1;73(5):475-477. https://doi.org/10.1016/S0009-9236(03)00015-8
Dreisbach, Albert W. ; Japa, Shanker ; Gebrekal, Aster B. ; Mowry, Sarah E. ; Lertora, Juan J.L. ; Kamath, Burde L. ; Rettie, Allan E. / Cytochrome P4502C9 activity in end-stage renal disease [2]. In: Clinical Pharmacology and Therapeutics. 2003 ; Vol. 73, No. 5. pp. 475-477.
@article{4dda155a9690457c8f9c7d948d928f9e,
title = "Cytochrome P4502C9 activity in end-stage renal disease [2]",
author = "Dreisbach, {Albert W.} and Shanker Japa and Gebrekal, {Aster B.} and Mowry, {Sarah E.} and Lertora, {Juan J.L.} and Kamath, {Burde L.} and Rettie, {Allan E.}",
year = "2003",
month = "5",
day = "1",
doi = "10.1016/S0009-9236(03)00015-8",
language = "English (US)",
volume = "73",
pages = "475--477",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Cytochrome P4502C9 activity in end-stage renal disease [2]

AU - Dreisbach, Albert W.

AU - Japa, Shanker

AU - Gebrekal, Aster B.

AU - Mowry, Sarah E.

AU - Lertora, Juan J.L.

AU - Kamath, Burde L.

AU - Rettie, Allan E.

PY - 2003/5/1

Y1 - 2003/5/1

UR - http://www.scopus.com/inward/record.url?scp=0038031678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038031678&partnerID=8YFLogxK

U2 - 10.1016/S0009-9236(03)00015-8

DO - 10.1016/S0009-9236(03)00015-8

M3 - Letter

VL - 73

SP - 475

EP - 477

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 5

ER -